It’s not often a rancher’s wife breaks down in tears, but 12 years ago, Brandon Ames, CEO, and founder of AniCell Biotech took an unexpected call from his mother that would launch a pivotal shift of regenerative veterinary medicine as we know it.

On the heels of having to euthanize her favorite mare a couple of months earlier, Janette Ames was now facing the same heartbreaking inevitability for her granddaughter’s horse. And why? Chemical founder. A lethal drug interaction between two corticosteroids; one to treat hock inflammation and one to treat colic. Not just $100,000 in prized show horses gone, but beloved companions, confidence builders, and exercise partners halted a once ACTIVE lifestyle of the Ames family.

Ames began to ask himself all of the “why” questions. “Why just focus on addressing the symptoms? Why couldn’t a technology be developed that was all-natural and not a drug… thus avoided the toxicity and lethality of inadvertent drug combinations? Over the years I had witnessed so many treatments used to address the symptoms of injuries and very few that actually solved the root cause of the issue.”

“I was aware of a new, all-natural regenerative technology being developed and used to help people that were showing promising results in orthopedic injuries and chronic wounds such as diabetic ulcers. We had used stem cells and other regenerative treatments in horses for years on the ranch, but they were invasive, time-consuming, and required painful harvesting of bone marrow or fat. Then, they needed to be cultured for up to three weeks before treatment could occur. Other solutions required our vets to purchase expensive equipment to provide the solutions for our horses requiring us to drive our horses 3 hours to have them treated. This new approach in humans simply recycled nature’s blessings by collecting the amniotic fluid during childbirth. Why not do the same thing for horses?”

Being a long-time entrepreneur, Ames assembled a team to research the use of amniotic material and components and began finding amazing results not only for the horse and owners but for the veterinarians using them.  Cellular Biologist and AniCell team member, Dr. Moises Barcelo DVM, Ph.D. said: “We’re also very excited about the prospects for the use of this technology.”

This technology is provisionally patented for use in horses and dogs and provides a bioscaffold as both a wound covering and physical barrier for a variety of wounds. Using this all-natural amniotic tissue, the wound environment is protected using a technology that is compatible with the animal’s own tissue.”

When referring to this new venture that finds himself uniting with others who are at the forefront of transforming veterinary medicine.  Ames says, “quite simply, we are in the recycling business, collecting the miracle of regenerative medicine from nature’s blessings that would otherwise end up on the ground.”